The 21st Century Cures Act—and Beyond

AAOS continues efforts to increase musculoskeletal research funding

As reported in the February 2017 issue of AAOS Now, one of the last legislative actions of 2016 was the passage of the 21st Century Cures Act (H.R. 34), which aims to provide “necessary resources to researchers to continue their efforts to uncover the next generation of cures and treatments.” In addition to streamlining some U.S. Food and Drug Administration (FDA) regulations, this important legislation increases research dollars for the National Institutes of Health (NIH) by $4.8 billion and implements a number of measures to encourage research and modernize clinical trials. The bill passed Congress with overwhelming support—the vote was 392-26 in the House and 94-5 in the Senate. The American Association of Orthopaedic Surgeons (AAOS) advocated for this bill because of its potential to advance patient care. 

To View Full Article You Must